Web NewDrugInformation.com

Locoid Drug - Locoid The trade name of the product as shown on the labeling. Dosage - SOLUTION; TOPICAL The product dosage form and route separated by a semi-colon. Active Ingredient(s) - Hydrocortisone Butyrate Multiple ingredients are in alphabetical order. Strength - 0.1% The potency of the active ingredient(s), Hydrocortisone Butyrate. May repeat for multiple part products. Applicant - YAMANOUCHI The firm name holding legal responsibility for Locoid. The firm name is condensed to a maximum twenty character unique string. New Drug Application (NDA) Number - 019819 The FDA assigned number to Locoid. Format is nnnnnn. Product Number - 001 The FDA assigned number to identify Locoid. Each strength is a separate product. May repeat for multiple part products. Format is nnn. Therapeutic Equivalence (TE) Code - The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products. Approval Date - Sep 15, 1988 The date Locoid was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982". Reference Listed Drug (RLD) - No The pioneer or innovator of Locoid. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No. Type - DISCN The group or category of approved drugs Locoid is in. Format is RX, OTC, DISCN. Applicant Full Name - Yamanouchi Europe Bv The full name of the firm holding legal responsibility for the new application of Locoid. Locoid Hydrocortisone Butyrate 0.1% Cream; Topical Locoid 0.1% Cream; Topical Locoid 0.1% Cream; Topical Locoid Lipocream 0.1% Cream; Topical Hydrocortisone Butyrate 0.1% Ointment; Topical Locoid 0.1% Ointment; Topical Locoid 0.1% Ointment; Topical Hydrocortisone Butyrate 0.1% Solution; Topical Locoid 0.1% Solution; Topical Locoid 0.1% Solution; Topical NewDrugInformation